BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• BioMidwest

  Aegis Analytical Corporation Discover 2010 Keynote Delivered by Human Genome Sciences, Inc. Randy Maddux

  June 7, 2010

   · 

  1 min read
• Drug Development

  BioSante Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for GVAX Chronic Myeloid Leukemia Cancer Vaccine

  June 7, 2010

   · 

  1 min read
• Drug Development

  Geron Corporation Presents Clinical Data on Its Telomerase Inhibitor Drug in Breast Cancer at American Society of Clinical Oncology

  June 7, 2010

   · 

  1 min read
• Biotech Beach

  Arrowhead Research Corporation, Leonardo BioSystems, Inc., Receives $2.5 Million Funding from Texas Emerging Technology Fund

  June 7, 2010

   · 

  1 min read
• Drug Development

  Celgene Corporation Release: Data from Study of Revlimid(R) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL) Presented at American Society of Clinical Oncology

  June 7, 2010

   · 

  1 min read
• Business

  CombinatoRx, Incorporated Receives Milestone Payment for Prednisporin Advancement

  June 7, 2010

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Presents Updated Clinical Data on Its Investigational Pan-BCR-ABL Inhibitor, AP24534, in Drug-Resistant Chronic Myeloid Leukemia

  June 7, 2010

   · 

  1 min read
• BioMidwest

  Prostate Cancer Foundation Announces University of Michigan Researchers Discover Melanoma Drug Target That Occurs in Prostate Cancer Patients

  June 7, 2010

   · 

  1 min read
• Drug Development

  Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company Report Positive Data on Retreatment with Brentuximab Vedotin (SGN-35) in Lymphoma

  June 7, 2010

   · 

  1 min read
• Drug Development

  Rosetta Genomics Ltd. Release: Data Presented at American Society of Clinical Oncology 2010 by M. D. Anderson Cancer Center Demonstrate the ability of miRvie(TM) mets to Identify the Most Likely Origin of Metastases in Cancer of Unknown Primary

  June 7, 2010

   · 

  1 min read